Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management Cover

.blurhash-client-img { display: none !important; }

Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management

Radiology and Oncology

Volume 58 (2024): Issue 2 (June 2024)

By: Milena Blaz Kovac and Bostjan Seruga

Open Access

|Apr 2024

Authors

Milena Blaz Kovac

Ljubljana Community Health Centre, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Bostjan Seruga

bseruga@onko-i.si

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2024-0027 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 170 - 178

Submitted on: Feb 22, 2024

|

Accepted on: Mar 10, 2024

|

Published on: Apr 14, 2024

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

potentially fatal toxicity,

immune checkpoint inhibitor,

chimeric antigen receptor T-cells,

Bispecific T-cell engager,

antibody dug conjugate,

immunosuppressive therapy

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2024 Milena Blaz Kovac, Bostjan Seruga, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 58 (2024): Issue 2 (June 2024)Next article